Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise

This publication has 31 references indexed in Scilit:

• Assessing clinical benefit in the treatment of pancreas cancer: Gemcitabine compared to 5-fluorouracil
  European Journal Of Cancer, 1997
• Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status
  Clinical Oncology, 1996
• Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus
  Clinical Oncology, 1995
• Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified?
  Lung Cancer, 1994
• Forthcoming Events
  European Journal of Cancer Care, 1994
• Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group.
  Thorax, 1993
• Doxorubicin in advanced breast cancer: Influence of schedule on response, survival and quality of life
  European Journal Of Cancer, 1992
• A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis
  European Journal Of Cancer, 1992
• A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
  European Journal of Cancer and Clinical Oncology, 1991
• Prospective randomised trial of laser therapy only and laser therapy followed by endoscopic intubation for the palliation of malignant dysphagia.
  Gut, 1990